ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 39 citations in OpenAlex.
- Trends in the Burden of Vision Impairment in Saudi Arabia, 1990-2023: A Global Burden of Disease Study Analysis.Journal of clinical medicine · 2026Article
- Prevalence and Causes of Visual Impairment and Blindness in the Qassim Region, Saudi Arabia: A Retrospective Study.Cureus · 2026Article
- Frequency and comorbidities of age-related macular degeneration in KSA: A retrospective multiregional study.Journal of Taibah University Medical Sciences · 2026Article
- Perception of Congenital Cataract among Saudi Parents in Saudi Arabia.Annals of African medicine · 2026Article
- Impact of surgical complexity and surgeon experience on phacoemulsification outcomes: a one-year retrospective study from a Saudi tertiary eye hospital.Frontiers in ophthalmology · 2026Article
- Global prevalence and years lived with disability (YLDs) of cataract in 204 countries and territories: findings from the Global Burden of Disease Study 2021.Eye (London, England) · 2025Article
- Diabetic retinopathy and dyslipidemia among patients with type 2 diabetes mellitus in the Jazan endocrine and diabetes center: A case-control study.Journal of family medicine and primary care · 2025Article
- Article
- Prevalence, Causes, and Risk Factors Associated with Visual Impairment in Qbah, a Rural Community in the Qassim Region of Saudi Arabia.Healthcare (Basel, Switzerland) · 2025Article
- Quantitative Analysis of Early Retinal Changes and OCT Parameters in Diabetic Subjects with and Without Retinopathy.Diagnostics (Basel, Switzerland) · 2025Article
- Low-Vision Rehabilitation Services in Saudi Arabia: A Nationwide Survey of Optometrists on Current Status and Future Directions.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Article
- A lightweight multi-deep learning framework for accurate diabetic retinopathy detection and multi-level severity identification.Frontiers in medicine · 2025Article
- Career choice of Saudi medical students: opting for ophthalmology residency programs - perceptions and sociodemographic influencing factors - a cross-sectional study in Northern Saudi Arabia.BMC medical education · 2024Article
- Awareness of the Risk of Chronic Use of Steroid Causing Cataract in Al Ahsa City, Saudi Arabia.Cureus · 2024Article
- Article
- Article
- Review
- Knowledge and Attitude Towards Corneal Donation: Saudi medical students' perspective.Sultan Qaboos University medical journal · 2022Article
- Causes of Visual Impairment Among the Registered Visually Disabled: A Retrospective Study.Cureus · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA major socio-economic development in Saudi Arabia affected the pattern and causes of visual impairment for the past 40 years. Moreover, an up-to-date summary of available data is vital for planning, monitoring, and evaluating national blindness prevention program.
aimThis study conducted to provide a summary overview of prevalence, causes, and changes in the pattern of blindness and visual impairment for the past 40 years among Saudi adults, with brief discussion of the related socio-economic and ecological factors.
methodsThe review was confined to the published epidemiological studies performed in Saudi Arabia covering the age group 18 year and older from 1985 onwards.
resultsSix epidemiological studies were included from 1985 onwards. In1986, the prevalence of blindness and visual impairment in Saudi Arabia were 1.5% and 7.8%, respectively which is 20 times the magnitude of blindness in the United States. Multiple regional population based studies conducted later in areas with disparate ecological and socio-economical determinants at different time intervals showed variable prevalence of blindness 3.3% Eastern Province 1986, 0.7% Bisha 1993. Recently, in older than 50 year population the reported prevalence was 2.6% Taif 2012 and 5.7% Jazan 2015 and 6.4% in Ahsa. Since 1986, the single leading cause of adult blindness in Saudi Arabia is cataract. Although, Trachoma reported to be the second primary cause of blindness on 1986, its burden is reduced in Jizan (2015) and minimal in Taif (2012) which is replaced by chronic diseases related etiologies i.e Diabetic Retinopathy.
conclusionEcological and socio-economical determinants play critical role in the magnitude and causes of blindness and visual impairment in Saudi Arabia. Significant data gaps obscure monitoring and evaluation of the eye health. Eye health indicators should be integrated into the national health information system for dynamic monitoring and evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.